Check-Cap (STU:7CC) ROE % Adjusted to Book Value: -17.54% (As of Dec. 2025)


STU:7CC Check-Cap Ltd STU:7CC
25 GF Score
Price €1.06
! 2 Warning Signs
View Full Analysis

What is Check-Cap ROE % Adjusted to Book Value?

Check-Cap STU:7CC -0.93% 25 ROE % Adjusted to Book Value is -17.54% as of Dec. 2025. GuruFocus rates STU:7CC with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

Check-Cap's ROE % for the quarter that ended in Dec. 2025 was -59.12%. Check-Cap's PB Ratio for the quarter that ended in Dec. 2025 was 3.37. Check-Cap's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -17.54%.

Check-Cap ROE % Adjusted to Book Value Related Terms

Check-Cap ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Check-Cap's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Check-Cap ROE % Adjusted to Book Value Chart

Check-Cap Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.76 -148.34 -100.11 0.00 135.39

Check-Cap Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -87.19 -94.32 0.00 829.94 -17.54

STU:7CC vs ADVB, XWEL, NDRA: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Check-Cap's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Check-Cap ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Check-Cap's ROE % Adjusted to Book Value falls into.


STU:7CC
25GF Score
Check-Cap Ltd STU:7CC
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Check-Cap ROE % Adjusted to Book Value Calculation

Check-Cap's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=456.26% / 3.37
=135.39%

Check-Cap's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-59.12% / 3.37
=-17.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -17.54% mean?
Check-Cap (STU:7CC) has a ROE % Adjusted to Book Value of -17.54% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Check-Cap and its competitors.
Is Check-Cap's ROE % Adjusted to Book Value too high?
Check-Cap's current ROE % Adjusted to Book Value is -17.54%. Overall, Check-Cap has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Check-Cap's ROE % Adjusted to Book Value compare to ADVB and XWEL?
Check-Cap's ROE % Adjusted to Book Value of -17.54% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Check-Cap and its competitors. Check-Cap's current ROE % Adjusted to Book Value is -17.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Check-Cap stock overvalued right now?
Check-Cap (STU:7CC) has a current ROE % Adjusted to Book Value of -17.54%. The current ROE % Adjusted to Book Value is -17.54%. Check-Cap's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Check-Cap (STU:7CC), the current ROE % Adjusted to Book Value is -17.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Check-Cap Business Description

Other Exchanges MBAI:USA
Address 29 Abba Hushi Avenue, P.O. Box 1271, Mount Carmel, Isfiya, ISR, 3009000
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
25GF Score

Get the complete analysis for STU:7CC

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price